The big picture of the week in business, direct to your inbox

View in browser /

 Manage your newsletters

Youtube Instagram Facebook Twitter

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

Read more

Germany’s family business lobby opens door to AfD, sparking backlash

Germany’s family-owned companies’ lobby has confirmed it is “saying goodbye to firewalls” against the far-right AfD as the party surges in national polling.

BHP scraps Anglo American copper mega-merger after repeat failed bids

Australian mining giant BHP has dropped its renewed bid for Anglo American after preliminary talks, clearing the way for the miner to move ahead with its own plans.


Why this ad?

Britain's IAG joins major European carriers in bidding race for Portugal’s TAP

Air France–KLM and Lufthansa have emerged as leading contenders to buy Portugal’s TAP. IAG — the owner of British Airways and Iberia — has also expressed interest as the government prepares the national carrier for privatisation.

Income needed to avoid poverty: How do European thresholds compare?

Millions of Europeans live in poverty, but the meaning of a comfortable income differs widely across the continent.


Why this ad?

‘Investing superheroes’: Here’s what to know about profit for purpose

Impact investors — representing the profit-for-purpose market, worth roughly $1.57 trillion worldwide — gathered in Malmö, Sweden, this week to examine emerging trends in the sector, including AI and defence.

The Big Question: Has Europe improved its competitiveness since the Draghi report?

“Member states would feel much more comfortable about ceding power to supranational European regulators if they thought they were pro-growth,” said former commissioner Lord Jonathan Hill.